StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The scale of the target cut is a notable negative signal, though the analyst's revised target still implies upside from the posted price.
What happened, with direct paths to the underlying reporting
Baird sharply lowered its Xylem price target from $165 to $123, a substantial negative revision. The new target remains above the reported share price of $92.86, so this is a bearish change in analyst expectations rather than a target below current price.
Target: $123
Posted price: $92.86
Analyst firm: Robert W. Baird
Analyst: Michael Halloran
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.